Virtus ETF Advisers’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,828
| Closed | -$71K | – | 352 |
|
|
2024
Q4 | $71K | Buy |
5,828
+1,600
| +38% | +$19.5K | 0.03% | 365 |
|
|
2024
Q3 | $70.8K | Buy |
4,228
+75
| +2% | +$1.26K | 0.03% | 426 |
|
|
2024
Q2 | $72.4K | Sell |
4,153
-6,028
| -59% | -$105K | 0.04% | 427 |
|
|
2024
Q1 | $173K | Sell |
10,181
-698
| -6% | -$11.9K | 0.09% | 297 |
|
|
2023
Q4 | $111K | Buy |
10,879
+2,475
| +29% | +$25.2K | 0.07% | 329 |
|
|
2023
Q3 | $76.1K | Sell |
8,404
-835
| -9% | -$7.56K | 0.05% | 370 |
|
|
2023
Q2 | $99.4K | Buy |
9,239
+756
| +9% | +$8.14K | 0.06% | 383 |
|
|
2023
Q1 | $86.8K | Sell |
8,483
-3,268
| -28% | -$33.4K | 0.05% | 370 |
|
|
2022
Q4 | $124K | Buy |
11,751
+3,065
| +35% | +$32.3K | 0.06% | 410 |
|
|
2022
Q3 | $111K | Buy |
8,686
+66
| +0.8% | +$843 | 0.04% | 408 |
|
|
2022
Q2 | $111K | Sell |
8,620
-1,321
| -13% | -$17K | 0.04% | 404 |
|
|
2022
Q1 | $104K | Sell |
9,941
-595
| -6% | -$6.23K | 0.05% | 297 |
|
|
2021
Q4 | $163K | Buy |
10,536
+3,611
| +52% | +$55.9K | 0.06% | 317 |
|
|
2021
Q3 | $156K | Sell |
6,925
-356
| -5% | -$8.02K | 0.07% | 333 |
|
|
2021
Q2 | $187K | Buy |
+7,281
| New | +$187K | 0.08% | 376 |
|